JP2008539271A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539271A5 JP2008539271A5 JP2008509143A JP2008509143A JP2008539271A5 JP 2008539271 A5 JP2008539271 A5 JP 2008539271A5 JP 2008509143 A JP2008509143 A JP 2008509143A JP 2008509143 A JP2008509143 A JP 2008509143A JP 2008539271 A5 JP2008539271 A5 JP 2008539271A5
- Authority
- JP
- Japan
- Prior art keywords
- cspcna
- antibody
- seq
- isoform
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67527505P | 2005-04-27 | 2005-04-27 | |
| US68961405P | 2005-06-09 | 2005-06-09 | |
| PCT/US2006/016096 WO2006116631A2 (en) | 2005-04-27 | 2006-04-27 | Cancer specific pcna isoform binding antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008539271A JP2008539271A (ja) | 2008-11-13 |
| JP2008539271A5 true JP2008539271A5 (enExample) | 2009-06-18 |
Family
ID=37215524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008509143A Pending JP2008539271A (ja) | 2005-04-27 | 2006-04-27 | ｃｓＰＣＮＡイソ型抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20080206140A1 (enExample) |
| EP (1) | EP1874823B1 (enExample) |
| JP (1) | JP2008539271A (enExample) |
| AU (1) | AU2006239318A1 (enExample) |
| CA (1) | CA2605745A1 (enExample) |
| EA (1) | EA200702361A1 (enExample) |
| MX (1) | MX2007013584A (enExample) |
| WO (1) | WO2006116631A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7294471B2 (en) * | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
| CA3023068C (en) | 2008-07-24 | 2022-06-21 | Indiana University Research And Technology Corporation | Cancer peptide therapeutics |
| WO2011044374A1 (en) * | 2009-10-07 | 2011-04-14 | Indiana University Research And Technology Corporation | Capcna peptide therapeutics for cancer |
| US8455200B2 (en) | 2009-10-15 | 2013-06-04 | Traxxsson, Llc | Measurement of PKA for cancer detection |
| WO2012173677A2 (en) * | 2011-03-23 | 2012-12-20 | Indiana University Research And Technology Corporation | Anticancer therapeutic agents |
| PL3122766T3 (pl) | 2014-03-24 | 2021-09-13 | IMMCO Diagnostics, Inc. | Ulepszone wykrywanie i diagnostyka przeciwciał przeciwjądrowych dla układowych i nieukładowych zaburzeń autoimmunologicznych |
| US10420840B2 (en) | 2015-04-10 | 2019-09-24 | Rll, Llc | Anticancer therapeutic agents |
| CA3047230A1 (en) * | 2016-12-15 | 2018-06-21 | The National Institute for Biotechnology in the Negev Ltd. | Anti-pcna monoclonal antibodies and use thereof |
| MA52889A (fr) | 2018-06-15 | 2021-04-21 | Flagship Pioneering Innovations V Inc | Augmentation de l'activité immunitaire par modulation de facteurs de signalisation post-cellulaires |
| EP3962493A2 (en) | 2019-05-03 | 2022-03-09 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor |
| US20230114107A1 (en) | 2019-12-17 | 2023-04-13 | Flagship Pioneering Innovations V, Inc. | Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly |
| EP4172323A1 (en) | 2020-06-29 | 2023-05-03 | Flagship Pioneering Innovations V, Inc. | Viruses engineered to promote thanotransmission and their use in treating cancer |
| US20220325287A1 (en) | 2021-03-31 | 2022-10-13 | Flagship Pioneering Innovations V, Inc. | Thanotransmission polypeptides and their use in treating cancer |
| KR20240026507A (ko) | 2021-06-29 | 2024-02-28 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 타노트랜스미션을 촉진시키도록 엔지니어링된 면역 세포 및 이의 용도 |
| WO2024077191A1 (en) | 2022-10-05 | 2024-04-11 | Flagship Pioneering Innovations V, Inc. | Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer |
| US20240269251A1 (en) | 2023-01-09 | 2024-08-15 | Flagship Pioneering Innovations V, Inc. | Genetic switches and their use in treating cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2305625A1 (en) * | 1997-09-29 | 1999-04-08 | University Of Maryland, Baltimore | Altered dna synthesome components as biomarkers for malignancy |
| US7294471B2 (en) * | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
| DE602004015064D1 (de) * | 2003-01-06 | 2008-08-28 | Wyeth Corp | Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs |
| US8574848B2 (en) * | 2006-09-13 | 2013-11-05 | Oncimmune Ltd. | Immunoassay methods |
-
2006
- 2006-04-27 EP EP06751685.6A patent/EP1874823B1/en not_active Expired - Lifetime
- 2006-04-27 US US11/912,704 patent/US20080206140A1/en not_active Abandoned
- 2006-04-27 CA CA002605745A patent/CA2605745A1/en not_active Abandoned
- 2006-04-27 JP JP2008509143A patent/JP2008539271A/ja active Pending
- 2006-04-27 AU AU2006239318A patent/AU2006239318A1/en not_active Abandoned
- 2006-04-27 EA EA200702361A patent/EA200702361A1/ru unknown
- 2006-04-27 MX MX2007013584A patent/MX2007013584A/es not_active Application Discontinuation
- 2006-04-27 WO PCT/US2006/016096 patent/WO2006116631A2/en not_active Ceased
-
2012
- 2012-05-22 US US13/477,419 patent/US9006396B2/en not_active Expired - Lifetime
-
2015
- 2015-03-12 US US14/645,498 patent/US20150259407A1/en not_active Abandoned
-
2018
- 2018-03-05 US US15/911,870 patent/US20180362626A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2434958T3 (es) | Método para detectar cáncer ginecológico | |
| EP2900265B1 (en) | Anti-uroplakin ii antibodies systems and methods | |
| US9840551B2 (en) | Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof | |
| JP2009528507A (ja) | Ｒｅｇ４タンパク質を用いて膵癌を診断する方法 | |
| US20120244076A1 (en) | csPCNA Isoform Antibodies And Uses Thereof | |
| AU2011239583A1 (en) | Monoclonal antibodies against HER2 antigens, and uses therefor | |
| CN108064343B (zh) | 用于前列腺癌分析的组合物和方法 | |
| EP2971047A1 (en) | Monoclonal antibodies to transferrin and transferrin receptor antigens, and uses thereof | |
| US9625461B2 (en) | Method of detecting cancer using delta-catenin | |
| ES2308824T3 (es) | Eliminacion de interferencias de los inmunoanalisis por medio de sustancias derivadas de las regiones marco que abarcan anticuerpos. | |
| JP2010502192A (ja) | Ｂｏｒｉｓアイソフォーム並びに疾患を検出及び治療する方法 | |
| KR101138460B1 (ko) | 항-ｆａｓｎ 자가면역 항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물 | |
| KR20130081952A (ko) | 암 진단용 바이오마커 및 이를 이용한 암세포 분리 방법 | |
| KR101439856B1 (ko) | 항-ａｔｉｃ 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물 | |
| CN103842503A (zh) | 上皮性卵巢癌标志物检测用抗体和上皮性卵巢癌判定方法 | |
| US9663567B2 (en) | Monoclonal antibodies against serotransferrin antigens, and uses therefor | |
| EP2707720A2 (en) | Diagnosis and prognosis of triple negative breast and ovarian cancer | |
| US20240239846A1 (en) | Methods of analysing a sample | |
| Cressey et al. | Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients | |
| EP2541249A1 (en) | EpCAM detection | |
| JP6729917B2 (ja) | ＥｐｈＡ２ Ｎ末端フラグメント抗体 | |
| CN111303289A (zh) | 抗人Tn型糖基化MUC1抗体及其用途 | |
| JP2010180168A (ja) | 胆管癌特異的糖鎖エピトープを認識するモノクローナル抗体 | |
| US20130143231A1 (en) | MST1/STK4 PHOSPHO-THREONINE 120 (pMST-T120) ANTIBODY | |
| CN102597772B (zh) | 5.9kDa肽的免疫学测定方法 |